CRISPR Therapeutics
CRSP
#3306
Rank
S$4.42 B
Marketcap
$51.25
Share price
1.48%
Change (1 day)
-32.35%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -$7.32

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.94. In 2022 the company made an earnings per share (EPS) of -$10.97 a decrease over its 2021 EPS that were of $6.54.

EPS history for CRISPR Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.32-33.3%
2022-$10.97-267.74%
2021$6.54-194.33%
2020-$6.93-576.58%
2019$1.45-132.36%
2018-$4.49100.58%
2017-$2.24159.42%
2016-$0.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.86-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA